MedTrace Logo

Dopaminergic Enhancement of Learning and Memory in Aphasia

NCT00102869 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-10-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether levodopa, in combination with a high frequency language training, is effective in boosting naming performance in patients with aphasia.

Conditions

  • Cerebrovascular Accident
  • Aphasia

Interventions

DRUG

levodopa

100mg levodopa per day over 10 days/ treatment phase

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Caterina Breitenstein, PhD · Dept. of Neurology, University Hospital Muenster, Germany

  • Stefan Knecht, MD · Dept. of Neurology, University Hospital Muenster, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2007-02-28
Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00102869 on ClinicalTrials.gov